Vertex Pharmaceuticals (VRTX)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 3 |
| Ownership rank: | 218 |
| % of all portfolios: | 0.034% |
| Hold Price * : | $414.13 |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q4 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 44.27% | 645 | 0.01 | |
| Q3 2023 | |||||
| ≡ | Tweedy Browne Co. - Tweedy Browne Value Fund | Reduce 3.65% | 700 | 0.06 | |
| Q2 2023 | |||||
| ≡ | Tweedy Browne Co. - Tweedy Browne Value Fund | Reduce 19.45% | 4,635 | 0.39 | |
| Q4 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 18,052 | 0.04 | |
| Q2 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 6,254 | 0.01 | |
| Q2 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 460 | 0.00 | |
| Q2 2015 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 524,867 | 1.00 | |
| Q2 2009 | |||||
| ≡ | Bill & Melinda Gates Foundation Trust | Sell 100.00% | 95,000 | 0.03 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.